Study on Bemarituzumab with Chemotherapy and Nivolumab Compared to Chemotherapy and Nivolumab for Untreated Advanced Gastric and Gastroesophageal Junction Cancer with FGFR2b Overexpression | Clinical Trial

Study on Bemarituzumab with Chemotherapy and Nivolumab Compared to Chemotherapy and Nivolumab for Untreated Advanced Gastric and Gastroesophageal Junction Cancer with FGFR2b Overexpression | Clinical Trial | Right2Hope